JP Patent

JP7278405B2 — 小細胞肺がんの治療におけるキアウラニブの使用

Assigned to Shenzhen Chipscreen Biosciences Co Ltd · Expires 2023-05-19 · 3y expired

What this patent protects

Patent listed against trametinib-dimethyl-sulfoxide.

Drugs covered by this patent

Patent Metadata

Patent number
JP7278405B2
Jurisdiction
JP
Classification
—
Expires
2023-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Chipscreen Biosciences Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.